Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

I01CX001803-01A2
Title: Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD
Principal Investigator:

Paulo R Shiroma

Location: Minneapolis, MN
Congressional District Code: 5
Research Service: Clinical Science R&D
Project Period: January 2021 - December 2024
FY 2021 Funding Amount: $232,091
Total Award Amount
(all years):
$1,191,652
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER


Excerpt:

Only sertraline and paroxetine are currently FDA‐approved to treat PTSD. Other psychotropics are equally limited to provide optimal respond. This efficacy gap may be particularly great in VA settings. The 2017 VA/DoD Clinical Practice Guideline for The Management of PTSD and Acute Stress Disorder recommends individual, manualized trauma-focused such as Prolonged Exposure (PE) over other pharmacologic interventions for the primary treatment of PTSD. However, a recent review of clinical trials of...



Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.